AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Wolfe Research Upgrades Abbvie (ABBV) to Peerperform on Valuation
June 27, 2019 9:30 AM EDTWolfe Research analyst Tim Anderson upgraded Abbvie (NYSE: ABBV) from Underperform to Peerperform with a price target of $74.00 (from $84.00).
Cites the recent pullback in the valuation for the upgrade.For an analyst ratings summary and ratings history on... More

